•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 

A10356 Summary:

BILL NOA10356
 
SAME ASSAME AS S07839
 
SPONSORBrennan
 
COSPNSRColton, Cymbrowitz, Dinowitz, Galef, Gunther, Lupardo, Miller, Stirpe, Duprey, McDonough, Montesano, Wozniak, Crespo, Jaffee, Otis, Seawright, Joyner, Crouch, Mosley, Graf, Jean-Pierre
 
MLTSPNSRHyndman, Lopez, Magee, Robinson, Schimel, Simon
 
Amd 3333, Pub Health L
 
Requires prescription bottles containing opioids to have a label affixed concerning the addictive nature of the drug.
Go to top

A10356 Memo:

NEW YORK STATE ASSEMBLY
MEMORANDUM IN SUPPORT OF LEGISLATION
submitted in accordance with Assembly Rule III, Sec 1(f)
 
BILL NUMBER: A10356
 
SPONSOR: Brennan (MS)
  TITLE OF BILL: An act to amend the public health law, in relation to labeling prescription bottles of opioids   PURPOSE: This bill will require manufacturers and software companies that prepare labels for prescription drugs, which are approved by the state, to contain a warning regarding the addictive properties of opioid drugs.   SUMMARY OF PROVISIONS: Section 1 - amends subdivision 2 of section 3333 of the Public Health Law to add a new paragraph (d) providing that a new warning must be added to labels of opioid drugs -- "Warning. This drug is highly addic- tive. Please consult your pharmacist or physician before using." Section 2 - provides that this act shall take effect ninety days after it shall have become law, and provides that any rule or regulation necessary for the implementation of this act on its effective date are authorized to be made and completed on or before such effective date.   JUSTIFICATION: The social and personal cost of opioid addiction is a critical issue for New York State, and indeed for the entire country. This bill simply provides a clear warning to patients that have been prescribed opioid drugs that the over-use of these drugs can lead to addiction. Hopefully such warning will help patients to be careful not to utilize these drugs any more than is absolutely necessary.   LEGISLATIVE HISTORY: New bill   FISCAL IMPLICATIONS: None   EFFECTIVE DATE: Immediately
Go to top